Strateos Closes $56 Million Series B Financing To Accelerate The Roll-Out Of Its Smartlab Of The Future Platform
Jun 08, 2021•about 4 years ago
Amount Raised
$56 Million
Round Type
series b
Description
Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, Ally Bridge Group, Black Diamond Ventures, Mack & Co., LLC, and Castor Ventures. With this financing, Strateos will continue to drive innovations on its SmartLab PlatformTM, which integrates data generation and AI-enablement with its unique and flexible automation to accelerate pharmaceutical and synthetic biology R&D.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech